首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF HEARTWOOD OF BIJASAR (PTEROCARPUS MARSUPIUM ROXB.) IN STREPTOZOTOCIN-NICOTINAMIDE INDUCED TYPE 2 DIABETIC RATS
【24h】

ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF HEARTWOOD OF BIJASAR (PTEROCARPUS MARSUPIUM ROXB.) IN STREPTOZOTOCIN-NICOTINAMIDE INDUCED TYPE 2 DIABETIC RATS

机译:比亚佐(斜纹夜蛾)心材乙醇提取物在链佐菌素-烟酰胺诱导的2型糖尿病大鼠中的抗抑郁活性。

获取原文
           

摘要

The antidiabetic potential of ethanolic extract of bijasar (Pterocarpus marsupium Roxb.) heartwood was evaluated in the streptozotocin-nicotinamide induced type 2 diabetic model. Graded doses of the ethanolic heartwood extract were administered to normal and experimental diabetic rats for 12 days. Significant (p < 0.05) reduction in fasting blood glucose levels were observed in the normal as well as in the treated diabetic animals. In addition, changes in body weight, serum lipid profiles, thiobarbituric acid reactive substance levels, glycosylated hemoglobin and liver glycogen levels assessed in the extract treated diabetic rats were compared with diabetic control and normal animals. Significant results were observed in the estimated parameters, thereby justifying the use of the bijasar heartwood by Indian herbal practitioners for treatment of diabetics in different part of the Indian subcontinent.
机译:在链脲佐菌素-烟酰胺诱导的2型糖尿病模型中评估了Bijasar(Pterocarpus marsupium Roxb。)心材乙醇提取物的抗糖尿病潜力。向正常和实验糖尿病大鼠施用分级剂量的乙醇心材提取物,持续12天。在正常以及治疗的糖尿病动物中,观察到空腹血糖水平显着降低(p <0.05)。另外,将在提取物治疗的糖尿病大鼠中评估的体重,血清脂质谱,硫代巴比妥酸反应性物质水平,糖基化血红蛋白和肝糖原水平的变化与糖尿病对照组和正常动物进行了比较。在估计的参数中观察到了显着的结果,从而证明印度草药从业者使用Bijasar心材治疗印度次大陆不同部分的糖尿病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号